Health Ministry notifies amendments to New Drugs and Clinical Trials Rules, 2019
GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·
Why in news
The Union Ministry of Health and Family Welfare amended the New Drugs and Clinical Trials (NDCT) Rules, 2019, to streamline drug development and reduce regulatory burdens for the pharmaceutical industry.
Background
The amendments replace test licence requirements for small-scale drug production with a prior-intimation mechanism. The rules also eliminate prior permission for certain low-risk Bioavailability/Bioequivalence studies and will be implemented via the National Single Window System (NSWS) and SUGAM portal.
Facts for Prelims
- BodySUGAM: An online portal for various regulatory approvals in the pharmaceutical sector.
- FactThe amendments replace test licence requirements with a prior-intimation mechanism for small-scale drug production.
- FactLow-risk Bioavailability/Bioequivalence studies no longer require prior permission under the amended rules.
- BodyNational Single Window System (NSWS): The platform through which these rule changes will be implemented.
For Mains
Q. Discuss how streamlining regulatory frameworks for clinical trials and drug development can enhance India's position as a global hub for pharmaceutical manufacturing.
Dimensions to cover in your answer
- Regulatory efficiency: Reducing processing timelines to accelerate the drug development life cycle.
- Ease of doing business: Transitioning from prior permission to prior-intimation for low-risk studies.
- Digital integration: Leveraging NSWS and SUGAM to minimize bureaucratic friction in pharmaceutical R&D.
Keywords: Regulatory Reform · Pharmaceutical R&D · Ease of Doing Business · Clinical Trials · Bioavailability · Single Window System
More Science & Technology notes
- ‘Imports Can Never Be Fully Eliminated’: Defence Secretary on Make in India · 3 February 2026
- Bengaluru hosts global summit on Diamond Open Access · 3 February 2026
- GSI to probe land subsidence in Godavari delta in Andhra Pradesh · 3 February 2026
- DRDO demonstrates SFDR technology, India joins elite missile capability club · 3 February 2026
- PSLV failures: Ajit Doval visits VSSC, holds meeting with Director · 3 February 2026
- Low-cost flexible biosensor for early heart attack detection developed by BITS–RMIT Univ · 3 February 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
Report a mistake →Ask for something →thesatyadheesh@gmail.com
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.